Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Bought by PNC Financial Services Group Inc.

PNC Financial Services Group Inc. increased its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 2.7% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 136,711 shares of the medical equipment provider’s stock after buying an additional 3,564 shares during the period. PNC Financial Services Group Inc.’s holdings in Intuitive Surgical were worth $71,358,000 as of its most recent filing with the SEC.

A number of other institutional investors have also modified their holdings of ISRG. Howard Capital Management Group LLC lifted its holdings in shares of Intuitive Surgical by 4.5% in the 3rd quarter. Howard Capital Management Group LLC now owns 2,125 shares of the medical equipment provider’s stock worth $1,044,000 after purchasing an additional 92 shares during the last quarter. Principal Financial Group Inc. increased its position in Intuitive Surgical by 1.5% in the third quarter. Principal Financial Group Inc. now owns 602,393 shares of the medical equipment provider’s stock worth $295,938,000 after buying an additional 9,194 shares during the period. Portside Wealth Group LLC lifted its stake in Intuitive Surgical by 15.5% in the third quarter. Portside Wealth Group LLC now owns 1,165 shares of the medical equipment provider’s stock valued at $572,000 after buying an additional 156 shares during the last quarter. Summit Global Investments acquired a new position in shares of Intuitive Surgical during the third quarter valued at $306,000. Finally, Capital Performance Advisors LLP bought a new position in shares of Intuitive Surgical during the third quarter worth about $38,000. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Stock Performance

NASDAQ ISRG opened at $518.26 on Friday. Intuitive Surgical, Inc. has a 1 year low of $364.17 and a 1 year high of $616.00. The business’s fifty day moving average is $571.36 and its two-hundred day moving average is $531.53. The stock has a market capitalization of $184.59 billion, a P/E ratio of 80.85, a P/E/G ratio of 5.85 and a beta of 1.43.

Insider Buying and Selling

In related news, SVP Mark Brosius sold 489 shares of Intuitive Surgical stock in a transaction dated Friday, March 7th. The stock was sold at an average price of $533.18, for a total value of $260,725.02. Following the transaction, the senior vice president now owns 2,091 shares of the company’s stock, valued at approximately $1,114,879.38. This trade represents a 18.95 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, EVP Myriam Curet sold 408 shares of the company’s stock in a transaction dated Tuesday, February 11th. The shares were sold at an average price of $589.75, for a total transaction of $240,618.00. Following the sale, the executive vice president now directly owns 353 shares of the company’s stock, valued at $208,181.75. This represents a 53.61 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 13,579 shares of company stock worth $7,756,844 in the last three months. 0.90% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

Several analysts recently weighed in on ISRG shares. Leerink Partners lifted their price objective on shares of Intuitive Surgical from $490.00 to $548.00 in a research report on Monday, January 27th. Bernstein Bank boosted their price objective on Intuitive Surgical from $655.00 to $700.00 and gave the stock an “overweight” rating in a research report on Monday, January 27th. Stifel Nicolaus raised their target price on Intuitive Surgical from $525.00 to $610.00 and gave the company a “buy” rating in a research report on Thursday, December 5th. Barclays lifted their target price on Intuitive Surgical from $610.00 to $674.00 in a research note on Monday, January 27th. Finally, Erste Group Bank raised Intuitive Surgical from a “hold” rating to a “buy” rating in a research note on Tuesday, November 19th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and sixteen have given a buy rating to the stock. According to MarketBeat, Intuitive Surgical presently has an average rating of “Moderate Buy” and an average target price of $613.10.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.